[1] [4] Additionally, semaglutide acts centrally on appetite centres in the brain to reduce hunger signals and food cravings
Melanotan 2 has no marketing authorization from the FDA, the EMA, or any comparable regulator, and (as noted above) the FDA approval of the Melanotan-2-derived molecule bremelanotide/Vyleesi does not launder Melanotan 2 into an approved product
Patients should be advised to eat slowly, chew thoroughly, and stop eating when comfortably satisfied rather than completely full, as overeating can exacerbate gastrointestinal symptoms
Patient Preference Ultimately, patient preference is crucial
Journal of Clinical Epidemiology, 47 (9), 10211026
Put off by the inclusion of WPC